Crossmark

Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients

Crossref DOI link: https://doi.org/10.1186/s13014-025-02585-z

Published Online: 2025-02-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Kai-Lin

Chi, Mau-Shin

Hao, Chung-Yu

Ko, Hui-Ling

Huang, Yi-Ying

Wu, Ren-Hong

Lai, Hung-Chih

Lin, Ying-Chu

Hao, Sheng-Po

Chi, Kwan-Hwa
Funding

Funding for this research was provided by:

Shin Kong Wu Ho-Su Memorial Hospital (2018SKHADR027)
License Information

Text and Data Mining valid from 2025-02-08

Version of Record valid from 2025-02-08
More Information

Article History

Received: 25 February 2024

Accepted: 13 January 2025

First Online: 8 February 2025

Declarations

:

: This phase II study was approved by the institutional review board of Shin Kong Wu Ho-Su Memorial Hospital (No. 20150205D).

: Consent for publication was obtained.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below